Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Esophageal Cancer Multimodal Prehabilitation Study [NA]
The Massachusetts General Hospital–sponsored esophageal cancer multimodal prehabilitation trial has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer [NA]
This document provides an update on a completed clinical trial exploring biological factors that predict treatment response in colorectal ca…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating a binary oncolytic adenovirus in combination with a HER2-specific autologous CAR-VST for advanced HER2-pos…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy [NA]
Completed clinical trial comparing Ivor-Lewis and McKeown minimally invasive esophagectomy for esophageal cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation [Phase 2]
A Phase 2 study of PRT3789 in combination with pembrolizumab for SMARCA4-mutant advanced or metastatic solid tumors was terminated. The stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation [Phase 1]
A Phase 1 study of PRT7732, an oral SMARCA2 degrader, in patients with SMARCA4-mutant advanced or metastatic solid tumors has been terminate…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A phase 1/2 study of TAK-500 with or without pembrolizumab in adults with select locally advanced or metastatic solid tumors; the trial was …
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer [Phase 2]
Phase 2 trial comparing oral cryotherapy with acupressure/acupuncture versus oral cryotherapy alone to prevent oxaliplatin-induced periphera…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal Cancer [Phase 2]
Phase 2 clinical trial evaluating stereotactic body radiation therapy (SBRT) in combination with immunotherapy for oligometastatic esophagea…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Impact of Arterial Partial Pressure of Oxygen on Anastomotic Leakage After Esophagectomy
A completed clinical trial evaluating whether arterial partial pressure of oxygen influences the risk of anastomotic leakage after esophagec…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating LVGN3616 and LVGN6051±LVGN7409 with nab-paclitaxel or bevacizumab and cyclophosphamide in various metastatic solid …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers [NA]
A completed clinical trial study examined determinants of patient delay in seeking medical consultation for esophageal cancer and gastric ad…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: QL1706 Plus Chemotherapy for Borderline Resectable Esophageal Cancer [Phase 2]
Phase 2 clinical trial evaluating QL1706 plus chemotherapy for borderline resectable esophageal cancer; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Feasibility Study CORPPS
Completed feasibility study CORPPS evaluating esophageal cancer and laryngeal cancer.
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and Survival [NA]
Clinical trial update on the timing of enteral feeding support in esophageal cancer patients, examining effects on muscle function and survi…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer [NA]
This clinical trial update evaluates the effectiveness of an educational program intended to enhance emotional competencies in patients unde…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
Clinical trial update reports the completion of a Phase 1/2 safety and efficacy study of CTX131 in adults with relapsed or refractory solid …
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer [Phase 2]
A Phase 2 clinical trial evaluating the combination of radiochemotherapy and immunotherapy for unresectable esophageal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 [Phase 1, Phase 2]
A phase 1/2 trial evaluating afuresertib in combination with sintilimab and chemotherapy in selected solid tumors resistant to prior PD-1/PD…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Evaluations of Alcohol Warning Labels [NA]
Completed clinical trial evaluating the impact of alcohol warning labels on cancer-related outcomes, with findings related to oral cancer, e…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Relationship Between Endoscopic Ultrasound Staging and Degree of Stricture in Esophageal Cancer
This completed clinical trial update examines the relationship between endoscopic ultrasound staging and the degree of stricture in esophage…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter [Phase 2]
A Phase 2 clinical trial investigating ALI after radiation therapy in patients with lung cancer and esophageal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors [Phase 2]
A Phase 2 trial evaluating niraparib in patients with advanced PALB2-mutated tumors was terminated; results have been posted for multiple so…
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies [Phase 1]
Open-label Phase 1 safety and tolerability study of INCB062079 in patients with advanced hepatocellular carcinoma and other malignancies; st…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer [NA]
This trial update describes the effects of zinc supplementation on quality of life in patients with gastrointestinal cancers. The study has …